Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pharmacogenetic approach for a better drug treatment in children.

Polanczyk G, Bigarella MP, Hutz MH, Rohde LA.

Curr Pharm Des. 2010;16(22):2462-73. Review.

PMID:
20513229
2.

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.

Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, Rohde LA.

Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):391-4.

PMID:
17171656
3.

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, Sasvari-Szekely M, Nemoda Z.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1431-5. doi: 10.1002/ajmg.b.30704.

PMID:
18214865
4.

Dopamine transporter genotype influences the physiological response to medication in ADHD.

Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM.

Brain. 2006 Aug;129(Pt 8):2038-46. Epub 2006 Jun 7.

PMID:
16760197
5.

[Meta-analysis of candidate genes in attention-deficit hyperactivity disorder].

Wohl M, Purper-Ouakil D, Mouren MC, Adès J, Gorwood P.

Encephale. 2005 Jul-Aug;31(4 Pt 1):437-47. French.

PMID:
16389711
6.
7.

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):201-8.

PMID:
17955457
8.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
9.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
10.

Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.

Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF.

Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. Epub 2009 Jan 8.

PMID:
19146920
11.

Candidate gene studies of attention-deficit/hyperactivity disorder.

Faraone SV, Khan SA.

J Clin Psychiatry. 2006;67 Suppl 8:13-20. Review.

12.

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

Purper-Ouakil D, Wohl M, Orejarena S, Cortese S, Boni C, Asch M, Mouren MC, Gorwood P.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1425-30. doi: 10.1002/ajmg.b.30809.

PMID:
18563707
13.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

14.

High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.

van der Meulen EM, Bakker SC, Pauls DL, Oteman N, Kruitwagen CL, Pearson PL, Sinke RJ, Buitelaar JK.

J Child Psychol Psychiatry. 2005 Oct;46(10):1074-80.

PMID:
16178931
15.
16.

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.

Polanczyk G, Zeni C, Genro JP, Roman T, Hutz MH, Rohde LA.

Pharmacogenomics. 2005 Apr;6(3):225-34. Review.

PMID:
16013954
17.

Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

Contini V, Rovaris DL, Victor MM, Grevet EH, Rohde LA, Bau CH.

Eur Neuropsychopharmacol. 2013 Jun;23(6):555-60. doi: 10.1016/j.euroneuro.2012.05.006. Epub 2012 Jun 17. Review.

PMID:
22709890
18.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
19.

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA.

J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1155-64. doi: 10.1097/CHI.0b013e3181bc72e3.

20.

Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.

Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ.

Mol Psychiatry. 2000 Jul;5(4):396-404.

PMID:
10889550

Supplemental Content

Support Center